Sailax Pharma Consulting
Preclinical Safety Assessments
Before a product can advance into clinical trials or reach the market, it must undergo rigorous preclinical safety assessments to demonstrate its safety profile. Regulatory authorities require well-documented toxicology data that establish product safety for human or consumer use. At Sailax Pharma Consulting, we provide comprehensive preclinical safety assessment services designed to meet global regulatory expectations. Our scientific and regulatory experts help organizations evaluate safety risks, design compliant studies, and compile documentation that supports successful submissions.
Service Overview
Before a product can advance into clinical trials or reach the market, it must undergo rigorous preclinical safety assessments to demonstrate its safety profile. Regulatory authorities require well-documented toxicology data that establish product safety for human or consumer use. At Sailax Pharma Consulting, we provide comprehensive preclinical safety assessment services designed to meet global regulatory expectations. Our scientific and regulatory experts help organizations evaluate safety risks, design compliant studies, and compile documentation that supports successful submissions.
Who we support
Pharmaceutical developers preparing IND, NDA, or ANDA submissions. Biotechnology firms advancing biologics, biosimilars, or gene/cell therapies. Medical device manufacturers requiring biocompatibility and toxicology studies. Nutraceutical and cosmetic companies ensuring consumer safety before launch.
Scope of Services
Explore the modules we tailor for your regulatory program.
Toxicology study design and planning aligned with product type
Value to Your Organization
Clear value at every stage of partnership.
Regulatory-ready toxicology data for smooth submissions
Reduced safety risks through early identification of potential concerns
Faster product development timelines by optimizing study designs
Cost savings with targeted, fit-for-purpose toxicology approaches
Global acceptance of studies aligned with ICH and OECD standards
Compliance Standards / Quality Controls
Our toxicology assessment practices follow: ICH M3 and S-series guidelines. OECD test guidelines for toxicology. FDA and EMA non-clinical safety requirements. GLP (Good Laboratory Practice) standards. ISO 10993 standards for medical device biocompatibility.